LegoChem Biosciences, Inc.

KOSDAQ 141080.KQ

LegoChem Biosciences, Inc. EBITDA Margin for the year ending December 31, 2023: -209.06%

LegoChem Biosciences, Inc. EBITDA Margin is -209.06% for the year ending December 31, 2023, a -61.05% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • LegoChem Biosciences, Inc. EBITDA Margin for the year ending December 31, 2022 was -129.81%, a -138.18% change year over year.
  • LegoChem Biosciences, Inc. EBITDA Margin for the year ending December 31, 2021 was -54.50%, a -0.57% change year over year.
  • LegoChem Biosciences, Inc. EBITDA Margin for the year ending December 31, 2020 was -54.19%, a -283.41% change year over year.
  • LegoChem Biosciences, Inc. EBITDA Margin for the year ending December 31, 2019 was 29.55%, a 131.71% change year over year.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
SV Wall Street
KOSDAQ: 141080.KQ

LegoChem Biosciences, Inc.

CEO Mr. Yong Zu Kim Ph.D.
IPO Date May 10, 2013
Location
Headquarters 10, Gukjegwahak 10-ro
Employees 157
Sector Healthcare
Industries
Pharmaceuticals 3D Printing Biotechnology Clinical Trials Cosmetics Drugstores & Retail Pharmacies Medical Instruments
Description

LegoChem Biosciences, Inc. a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, and oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It offers its products in the forms of tablets and capsules. The Company also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.

StockViz Staff

February 4, 2025

Any question? Send us an email